Débora Silva Marques de Sousa

Débora Silva Marques de Sousa

Auto-generated profile, based on publicly available information

Débora Silva Marques de Sousa

Department of Clinical Analysis, São Paulo State University Júlio de Mesquita Filho (UNESP), School of Pharmaceutical Sciences of Araraquara

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Venomous Animals and Toxins including Tropical Diseases
Verified
Journal Article
Open access
ASAlessandra Aguirra Sani
Alessandra Aguirra Sani
Ana Flávia Marques PereiraAna Flávia Marques Pereira
Ana Flávia Marques Pereira
AFAlessandra Furlanetto
Alessandra Furlanetto
DSDébora Silva Marques de Sousa
Débora Silva Marques de Sousa
TZTatiane Baptista Zapata
Tatiane Baptista Zapata
AJAry Fernandes Junior
Ary Fernandes Junior
Natural products represent important sources of antimicrobial compounds. Propolis and compounds from essential oils comprise good examples of such substances because of their inhibitory effects on bacterial spores, including bee pathogens. Ethanol extracts of propolis (EEP) from Apis mellifera were prepared using different methods: double ultrasonication, double maceration and maceration associated with ultrasonication. Together with the antimicrobial peptides nisin and melittin, and compounds present in the essential oils of clove (Syzygium aromaticum) and cinnamon (Cinnamomum zeylanicum), assays were carried out on one Bacillus subtilis isolate and Paenibacillus alvei (ATCC 6344) against vegetative and sporulated forms, using the resazurin microtiter assay. Synergism with all the antimicrobials in association with tetracycline was verified by the time-kill curve method. Potassium and phosphate efflux, release of proteins and nucleic acids were investigated. EEPs showed the same MIC, 156.25 µg/mL against B. subtilis and 78.12 µg/mL against P. alvei. The peptides showed better activities against B. subtilis (MIC of 12 µg/mL for melittin and 37.50 µg/mL for nisin). Antimicrobials showed similar inhibitory effects, but cinnamaldehyde (39.06 µg/mL) showed the best action against P. alvei. Melittin and nisin showed the greatest capacity to reduce spores, regarding B. subtilis there was a 100% reduction at 6.25 and 0.78 µg/mL, respectively. Concerning P. alvei, the reduction was 93 and 98% at concentrations of 80 µg/mL of melittin and 15 µg/mL of nisin. EEPs showed the highest effects on the protein release against B. subtilis and P. alvei. Nucleic acid release, phosphate and potassium efflux assays indicated bacterial cell membrane damage. Synergism between antimicrobials and tetracycline was demonstrated against both bacteria. All antimicrobials tested showed antibacterial activities against vegetative and sporulated forms of P. alvei and B. subtilis, especially nisin and melittin. Synergism with tetracycline and damage on bacterial cell membrane also occurred.

1 January 2025 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
DSDébora Silva Marques de Sousa
Débora Silva Marques de Sousa
LRLuciana Silva Ruiz
Luciana Silva Ruiz
Ana Flávia Marques PereiraAna Flávia Marques Pereira
Ana Flávia Marques Pereira
ASAlessandra Aguirra Sani
Alessandra Aguirra Sani
TZTatiane Baptista Zapata
Tatiane Baptista Zapata
SBSandra de Moraes Gimenes Bosco
Sandra de Moraes Gimenes Bosco
Antimicrobial drug resistance is a challenge to public health. Various microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, carbapenemase-producing Klebsiella pneumoniae, Pythium insidiosum, and Candida auris, have developed resistance to commonly used antimicrobials in infection disease treatments. Consequently, there is an urgent need to explore and develop novel therapeutic drugs. Natural products, particularly medicinal plants, have received attention in the quest for innovative treatments for various diseases. Plantago major is a plant endowed with several biological properties, such as antibacterial, antifungal, and healing actions. This study aimed to investigate the antimicrobial activities of the methanolic extract obtained from the leaves of P. major. Microdilution assays were conducted to determine the minimum inhibitory concentration and minimum bactericidal and fungicidal concentration. Additionally, synergism with antimicrobial drugs was assessed using a time-kill curve analysis. A synergistic bactericidal interaction between the extract and imipenem was observed against carbapenemase-producing K. pneumoniae. For MRSA, a bacteriostatic synergism was noted in combinations of the extract with cephalotin and oxacillin. For C. auris, a fungistatic interaction was observed between the extract and amphotericin B. These results suggest the presence of bioactive compounds within the extract with therapeutic potential for combating infections caused by these microorganisms.

4 August 2025 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
DSDébora S M de Sousa
Débora S M de Sousa
GMGabrielle P M Monari
Gabrielle P M Monari
CRCassiana F da Rosa
Cassiana F da Rosa
JMJacobus F. Meis
Jacobus F. Meis
APAna Flavia M Pereira
Ana Flavia M Pereira
LRLuciana Silva Ruiz
Luciana Silva Ruiz
Aims: Candida auris has been reported on all continents, becoming a global threat due to high levels of resistance to all antifungal classes. In addition, this pathogen has lower susceptibility to disinfectants used in hospitals, favoring its stay in such environments. Evaluate the action of eugenol and cinnamaldehyde against Candida auris. Methods and results: The products were evaluated through sensitivity tests of broth microdilution, as well as their possible mechanisms of action using proteomic analysis. For microdilution was used 24 strains and for synergistic interactions was used 2 strains. Cytotoxicity of these products was verified in Vero cells. Eugenol and cinnamaldehyde showed fungicidal action at concentrations ranging from 31.25 to 250 µg/mL. Combinations of eugenol and cinnamaldehyde with itraconazole showed either antagonistic effects or no detectable interaction. No cytotoxicity was found for eugenol at the concentrations that caused yeast growth inhibition. On the other hand, cinnamaldehyde was cytotoxic at the same concentrations. According to proteomic analysis, the mechanism of action of eugenol and cinnamaldehyde is possibly related to the biosynthesis of ergosterol. Conclusion: The present results suggest eugenol as a possible candidate for the development of formulations to treat infections caused by C. auris.

8 September 2026 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
DSDébora Silva Marques de Sousa
Débora Silva Marques de Sousa
ACAna Karla Lima Freire Cabral
Ana Karla Lima Freire Cabral
BABruno Bulgarelli Adorno Arantes
Bruno Bulgarelli Adorno Arantes
JSJúlia Hatsue Araújo Sato
Júlia Hatsue Araújo Sato
GMGabrielle Pires de Morais Monari
Gabrielle Pires de Morais Monari
Maria José Soares Mendes GianniniMaria José Soares Mendes Giannini
Maria José Soares Mendes Giannini
Candidozyma auris has emerged as one of the most formidable fungal pathogens of the modern era, designated a critical priority pathogen by the World Health Organization due to its multidrug resistance, thermotolerance, and capacity to cause prolonged outbreaks in healthcare settings. Unlike most fungal pathogens, C. auris exhibits a remarkable tropism for human skin, where it persists asymptomatically, forms biofilm-like structures resistant to conventional antiseptics, and serves as a reservoir for nosocomial transmission. Invasive infections, particularly candidemia, carry mortality rates of 40-60% and disproportionately affect immunocompromised individuals and those with prolonged healthcare exposure. Six geographically distinct clades have been described, each differing in antifungal susceptibility, colonization capacity, and virulence. Despite the clinical urgency, the molecular and immunological mechanisms governing cutaneous colonization, persistence, and the transition to invasive infection remain poorly understood. This review examines the biology, virulence, and skin colonization dynamics of C. auris, with emphasis on experimental models (i.e. murine, porcine, and human skin systems) that have advanced our understanding of host-pathogen interactions, immune responses, and the efficacy of antifungal and decolonization strategies, highlighting critical knowledge gaps and future research priorities.